NCT06525012

Brief Summary

The aim of our study is to analyze mortality and sequelae of subarachnoid hemorrhage of aneurysmal origin in hospitalized patients in Martinique. Predictive factors of poor prognosis will also be analyzed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
122

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 19, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

July 24, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 29, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

March 31, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

July 24, 2024

Last Update Submit

March 26, 2025

Conditions

Keywords

SAH (Subarachnoid Hemorrhage)Ruptured intracranial aneurysmModified Rankin scoreMortalityPatient autonomyPatient dependence

Outcome Measures

Primary Outcomes (1)

  • Evaluate mortality in patients hospitalized for subarachnoid hemorrhage of aneurysmal origin over a 9-year period (2013-2021) in Martinique.

    Mortality of subarachnoid hemorrhage of aneurysmal origin.

    6 months

Secondary Outcomes (4)

  • Evaluate the clinical outcome of these patients.

    6 months

  • Analyze the factors associated with a significant impairment of autonomy and/or dependence.

    6 months

  • Analyze the factors associated with death.

    6 months

  • Analyze the factors associated with a poor prognosis (death AND/OR significant impairment of autonomy/dependence).

    6 months

Study Arms (1)

SAH of aneurysmal origin in hospitalized patients in Martinique between 2013 and 2021

Other: Usual patient care for patients hospitalized for subarachnoid hemorrhage of aneurysmal origin

Interventions

During hospitalization (2013-2021), patients were managed after multidisciplinary consultation in accordance with national recommendations between resuscitators, neurosurgeons and neuroradiologists, depending on the severity of the initial management and the patient's comorbidities, either by interventional radiology, neurosurgery or medical treatment.

SAH of aneurysmal origin in hospitalized patients in Martinique between 2013 and 2021

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients hospitalized in Martinique for subarachnoid hemorrhage of aneurysmal origin

You may qualify if:

  • Adult (≥18 years) patients,
  • Admitted to University Hospital of Martinique with subarachnoid hemorrhage of aneurysmal origin between 01/01/2013 and 31/12/2021,
  • Informed patient/next-of-kin/treating physician consent for research participation.

You may not qualify if:

  • Other causes of subarachnoid hemorrhage of non-aneurysmal origin (traumatic, arteriovenous malformation, cerebral tumor, cerebral thrombophlebitis).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Center of Martinique

Fort-de-France, 97261, Martinique

RECRUITING

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Pauline PICHOIS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2024

First Posted

July 29, 2024

Study Start

July 19, 2024

Primary Completion

December 31, 2024

Study Completion

April 1, 2025

Last Updated

March 31, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations